BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7393237)

  • 21. Preparation and application of a fluorescein-labeled peptide for determining the affinity constant of a monoclonal antibody-hapten complex by fluorescence polarization.
    Jiskoot W; Hoogerhout P; Beuvery EC; Herron JN; Crommelin DJ
    Anal Biochem; 1991 Aug; 196(2):421-6. PubMed ID: 1776694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of antibody--hapten reactions.
    Froese A; Sehon AH
    Contemp Top Mol Immunol; 1975; 4():23-54. PubMed ID: 209
    [No Abstract]   [Full Text] [Related]  

  • 23. Different affinities of mono-, di- and tri-DNP- ribonuclease A for anti-DNP antibody.
    Taniuchi S; Honjoh T; Tamoto K; Nakamura T; Koyama J
    Mol Immunol; 1981 Apr; 18(4):301-9. PubMed ID: 7300832
    [No Abstract]   [Full Text] [Related]  

  • 24. Characterization of high-affinity antifluorescyl IgM antibodies.
    Holzman RB; Voss EW
    Mol Immunol; 1981 Oct; 18(10):915-24. PubMed ID: 7335084
    [No Abstract]   [Full Text] [Related]  

  • 25. Location and dynamics of a membrane-bound fluorescent hapten. A spectroscopic study.
    Stanton SG; Kantor AB; Petrossian A; Owicki JC
    Biochim Biophys Acta; 1984 Oct; 776(2):228-36. PubMed ID: 6477909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence measurements of immune complexes of Mab 4-4-20 with isomeric haptens.
    Swindlehurst CA; Voss EW
    Biophys J; 1991 Mar; 59(3):619-28. PubMed ID: 1904783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of binding reactions of an antibody molecule with haptens on a membrane surface.
    Kobayashi M; Nakanishi M; Tsuboi M
    J Biochem; 1982 Jan; 91(1):407-9. PubMed ID: 6896049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of fluorescein labels on the affinity of antisera to small haptens.
    Colbert DL; Eremin SA; Landon J
    J Immunol Methods; 1991 Jul; 140(2):227-33. PubMed ID: 2066570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Charge transfer between fluorescein and tryptophan as a possible interaction in the binding of fluorescein to anti-fluorescein antibody.
    Gudgin Templeton EF; Ware WR
    Mol Immunol; 1985 Jan; 22(1):45-55. PubMed ID: 3838361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase of conformational stability of homogeneous rabbit immunoglobulin G after hapten binding.
    Závodszky P; Jaton JC; Venyaminov SY; Medgyesi GA
    Mol Immunol; 1981 Jan; 18(1):39-46. PubMed ID: 7266478
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic and fluorescence studies of affinity maturation in related antibodies.
    Pauyo T; Hilinski GJ; Chiu PT; Hansen DE; Choi YJ; Ratner DI; Shah-Mahoney N; Southern CA; O'Hara PB
    Mol Immunol; 2006 Mar; 43(7):812-21. PubMed ID: 16137768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and specificity of the anti-digoxin antibody 40-50.
    Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
    J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of purified precipitating and non-precipitating (coprecipitating) antibodies with hapten and with haptenated protein. Evidence of an asymmetric antibody molecule.
    Ronco JR; Sciutto E; Leoni J; Margni RA; Binaghi RA
    Immunology; 1984 Jul; 52(3):449-56. PubMed ID: 6745995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quenching of fluorescein-conjugated lipids by antibodies. Quantitative recognition and binding of lipid-bound haptens in biomembrane models, formation of two-dimensional protein domains and molecular dynamics simulations.
    Ahlers M; Grainger DW; Herron JN; Lim K; Ringsdorf H; Salesse C
    Biophys J; 1992 Sep; 63(3):823-38. PubMed ID: 1420916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescence polarization and intensity kinetic studies of antifluorescein antibody obtained at different stages of the immune response.
    Levison SA; Hicks AN; Portmann AJ; Dandliker WB
    Biochemistry; 1975 Aug; 14(17):3778-86. PubMed ID: 1236740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonprecipitating asymmetric antibodies.
    Margni RA; Binaghi RA
    Annu Rev Immunol; 1988; 6():535-54. PubMed ID: 3289577
    [No Abstract]   [Full Text] [Related]  

  • 37. First order dissociation rates between a subpopulation of high affinity rabbit anti-fluorescyl IgG antibody and homologous ligand.
    Watt RM; Herron JN; Voss EW
    Mol Immunol; 1980 Oct; 17(10):1237-43. PubMed ID: 7007873
    [No Abstract]   [Full Text] [Related]  

  • 38. The free energy of angular position of the Fab arms of IgG antibody.
    Schumaker VN; Seegan GW; Smith CA; Ma SK; Rodwell JD; Schumaker MF
    Mol Immunol; 1980 Mar; 17(3):413-23. PubMed ID: 7442683
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative analysis of the immunological evolution of antibody 28B4.
    Yin J; Mundorff EC; Yang PL; Wendt KU; Hanway D; Stevens RC; Schultz PG
    Biochemistry; 2001 Sep; 40(36):10764-73. PubMed ID: 11535051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison by 1H NMR of the hapten environment in the combining site of the dinitrophenyl binding IgA protein 315 and its fragments.
    Morris AT; Givol D; Dwek RA
    Immunochemistry; 1978 Aug; 15(8):519-22. PubMed ID: 730222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.